Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise Centers.
Lucia NappiMargaret OttavianoPasquale RescignoMarianna TortoraGiuseppe L BannaGiulia BaciarelloUmberto BassoChristina CanilAlessia CavoMaria Cossu RoccaPiotr CzaykowskiUgo De GiorgiXavier Garcia Del MuroMarilena Di NapoliGiuseppe FornariniJourik A GietemaDaniel Y C HengSebastien J HotteChristian KollmannsbergerMarco MaruzzoCarlo MessinaFranco MorelliSasja MulderCraig NicholsFranco NolèChristoph OingTeodoro SavaSimona SecondinoGiuseppe SimoneDenis SoulieresBruno VincenziPaolo A ZucaliSabino De PlacidoGiovannella Palmierinull nullnull nullnull nullPublished in: The oncologist (2020)
Despite the chaos, disruptions, and fears fomented by the COVID-19 illness, oncology care teams in Italy, other European countries, and Canada are delivering the enormous promise of curative management strategies for patients with testicular cancer and other germ cell tumors. At the same time, these teams are applying safe and innovative solutions and sharing best practices to minimize frequency and intensity of patient contacts with thinly stretched health care capacity.